AI-assisted, human-published
01/24/2024 /Startups/Founders
Precision Medicine Company Synnovation Therapeutics Launches with $102M Series A Funding
Synnovation Therapeutics launches with a $102 million Series A funding round led by Third Rock Ventures, focusing on developing small molecule therapies for highly validated disease targets.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com